Rocuronium Bromide
Product Images NDC 71872-7202

6 FDA label images from Medical Purchasing Solutions, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rocuronium Bromide (NDC 71872-7202). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71872-7202-1.pdp (71872 7202 1)

71872-7202-1.pdp (71872 7202 1)
Label for Rocuronium Bromide Injection, USP 50 mg per 5 mL (10 mg per mL) in a 5 mL multi-dose vial. The label includes usage warnings, storage instructions, active ingredient concentration, and manufacturer information. It indicates the product is repackaged and distributed by Medical Purchasing Solutions, LLC, Scottsdale, AZ, with original manufacture by Sagent Pharmaceuticals, Schaumburg, IL.*
FDA Label Image

Structural Formula (Roc01 0017 01)

Structural Formula (Roc01 0017 01)
Chemical structure of rocuronium bromide showing its molecular framework, including cyclic groups, hydroxyl and methyl groups, the N+ cationic center, and bromide ion (Br-).*
FDA Label Image

Figure 1 (Roc01 0017 02)

Figure 1 (Roc01 0017 02)
A box plot chart displaying data categorized by age groups and doses. The x-axis shows age groups 18-64 years, >=65 years, and 1-12 years with corresponding dose levels .45, .9, 1.2, and .6. The y-axis represents time in minutes. Outliers are indicated as individual points above some boxes.*
FDA Label Image

Figure 2 (Roc01 0017 03)

Figure 2 (Roc01 0017 03)
A box-and-whisker plot chart showing data distribution of rocuronium bromide duration by age groups and smoking status. The x-axis categorizes subjects as 18-64 years, 65 and older, 3 months to 1 year, and 1 to 12 years, each subdivided by smoking status (smoker or non-smoker). The y-axis represents duration in minutes, with data points and box plots illustrating variability.*
FDA Label Image

Figure 3 (Roc01 0017 04)

Figure 3 (Roc01 0017 04)
A line chart depicting minutes as a function of dose number with two plotted lines labeled 0.15 mg/kg and 0.1 mg/kg. The chart includes sample sizes (N=13 and N=29) for each dosage group and shows trends over six dose administrations.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Roc01 0017 05)

Package Label – Principal Display Panel – Vial Label (Roc01 0017 05)
Label for Rocuronium Bromide Injection 50 mg per 5 mL (10 mg per mL) by Medical Purchasing Solutions, LLC. The label shows a 5 mL multi-dose vial, intended for intravenous use only. It includes a warning for the product as a paralyzing agent and storage instructions to refrigerate between 2 and 8°C, avoid freezing, and use vials within 30 days after opening. The label also features the NDC 25021-662-05 and manufacturer information for SAGENT Pharmaceuticals.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.